Does NIMOTUZUMAB Cause Myelosuppression? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Myelosuppression have been filed in association with NIMOTUZUMAB. This represents 25.3% of all adverse event reports for NIMOTUZUMAB.
21
Reports of Myelosuppression with NIMOTUZUMAB
25.3%
of all NIMOTUZUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Myelosuppression From NIMOTUZUMAB?
Of the 21 reports, 13 (61.9%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIMOTUZUMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does NIMOTUZUMAB Cause?
Disease progression (12)
Off label use (10)
Product use in unapproved indication (6)
Anaemia (5)
Encephalitis autoimmune (5)
Fatigue (5)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)